TSX •
Healthcare •
Biotechnology •
Quote as of 07/03/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization6.13 mln
Float1.86 mln
Earnings Date08/13/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
94
/ 100
Top performer
Debt / Equity
-1.03
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Aptose Biosciences is a Canadian drug development company focused on creating new treatments for blood cancers that currently have limited options. Its two lead drugs, tuspetinib and luxeptinib, are taken by mouth and work by blocking specific proteins that drive the growth of leukemia and related cancers. The company works alongside partners in South Korea and the United States to advance these treatments through clinical trials. Founded in 1986 and based in Toronto, Aptose operates primarily in the American market.
